Suppr超能文献

小型片剂作为一种灵活的药物递送工具的可行性。

Feasibility of mini-tablets as a flexible drug delivery tool.

作者信息

Mitra Biplob, Chang Jessica, Wu Sy-Juen, Wolfe Chad N, Ternik Robert L, Gunter Thomas Z, Victor Michael C

机构信息

Clinical and Product Development, Eli Lilly and Company, Indianapolis, IN, USA; Drug Product Development, Celgene Corporation, Summit, NJ, USA.

College of Pharmacy, Purdue university, West Lafayette, IN, USA.

出版信息

Int J Pharm. 2017 Jun 15;525(1):149-159. doi: 10.1016/j.ijpharm.2017.04.037. Epub 2017 Apr 18.

Abstract

Mini-tablets have potential applications as a flexible drug delivery tool in addition to their generally perceived use as multi-particulates. That is, mini-tablets could provide flexibility in dose finding studies and/or allow for combination therapies in the clinic. Moreover, mini-tablets with well controlled quality attributes could be a prudent choice for administering solid dosage forms as a single unit or composite of multiple mini-tablets in patient populations with swallowing difficulties (e.g., pediatric and geriatric populations). This work demonstrated drug substance particle size and concentration ranges that achieve acceptable mini-tablet quality attributes for use as a single or composite dosage unit. Immediate release and orally disintegrating mini-tablet formulations with 30μm to 350μm (particle size d) acetaminophen and Compap™ L (90% acetaminophen) at concentrations equivalent to 6.7% and 26.7% acetaminophen were evaluated. Mini-tablets achieved acceptable weight variability, tensile strength, friability, and disintegration time at a reasonable solid fraction for each formulation. The content uniformity was acceptable for mini-tablets of 6.7% formulations with ≤170μm drug substance, mini-tablets of all 26.7% formulations, and composite dosage units containing five or more mini-tablets of any formulation. Results supported the manufacturing feasibility of quality mini-tablets, and their applicability as a flexible drug delivery tool.

摘要

除了通常被视为多颗粒剂型外,迷你片作为一种灵活的药物递送工具具有潜在应用。也就是说,迷你片在剂量探索研究中可提供灵活性,和/或在临床中实现联合治疗。此外,对于吞咽困难的患者群体(如儿科和老年人群体),质量属性得到良好控制的迷你片作为单一单元或多个迷你片的组合来给药固体剂型可能是一个明智的选择。这项工作展示了原料药粒径和浓度范围,这些范围能实现可接受的迷你片质量属性,以用作单一或复合剂型单元。对含有30μm至350μm(粒径d)对乙酰氨基酚和Compap™ L(90%对乙酰氨基酚)的速释和口腔崩解迷你片制剂进行了评估,其浓度相当于6.7%和26.7%的对乙酰氨基酚。对于每种制剂,迷你片在合理的固体分数下实现了可接受的重量变异、拉伸强度、脆碎度和崩解时间。对于含≤170μm原料药的6.7%制剂的迷你片、所有26.7%制剂的迷你片以及包含任何制剂的五个或更多迷你片的复合剂型单元,含量均匀度是可接受的。结果支持了高质量迷你片的制造可行性及其作为灵活药物递送工具的适用性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验